Oltmans Curtis Gale
Chief Legal Officer
Oltmans Curtis Gale has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 17, 2025.
On the most recent filing, Oltmans Curtis Gale is listed as Chief Legal Officer at Fulcrum Therapeutics, Inc. Inside the rolling window, Oltmans Curtis Gale reported no open-market purchases and 1 open-market sale totaling $45K in FULC.
Companies traded
Other insiders at FULC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$45K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Oltmans Curtis Gale made?
Oltmans Curtis Gale has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.
Which companies does Oltmans Curtis Gale trade?
Oltmans Curtis Gale has filed SEC Form 4 disclosures for 1 company, including FULC.
When was Oltmans Curtis Gale's most recent SEC Form 4 filing?
Oltmans Curtis Gale's most recent SEC Form 4 filing on Tracefour is dated Dec 17, 2025.
What is Oltmans Curtis Gale's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Oltmans Curtis Gale is listed as Chief Legal Officer.
What is Oltmans Curtis Gale's total buy and sell value in the current window?
Inside the rolling retention window, Oltmans Curtis Gale bought $0 and sold $45K based on SEC Form 4 filings.
What was Oltmans Curtis Gale's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,452 FULC shares on 2025-12-15, worth $45K, per SEC Form 4 filings.